Mental health in Parkinson’s disease after receiving aquatic therapy: a clinical trial
- 144 Downloads
Depression is a major determinant of quality of life in individuals with Parkinson’s disease. The aim of this study was to evaluate the effects of a program of Ai Chi aquatic therapy on pain, depression and quality of life in people with Parkinson’s disease. Participants were randomized to receive dry land physiotherapy treatment (control group) or aquatic Ai Chi sessions in the pool (experimental group). The outcome measures used included the VAS pain scale, the Geriatric Depression Scale and the SF-36 quality of life scale. In the experimental group treated with aquatic therapy, significant differences were found in the pain, depression and quality of life variables post-treatment (p < 0.001). In the control group, improvements were only observed in the VAS pain scale, and these were less significant than the changes found in the experimental group (p = 0.006). The significant changes registered in the experimental group at the post-treatment assessment were maintained 1 month after completing the experimental intervention program. In conclusion, these findings indicate that physical exercise performed in water has positive effects on some of the factors that influence mood and quality of life in people with Parkinson’s disease.
KeywordsDepression Exercise Parkinson’s disease Pain Quality of life
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
The author declares that there is no conflict of interest.
The study procedures were performed according to the Declaration of Helsinki, and approved by the Bioethics Committee of the main author’s institution (UALBIO2017/008).
All participants signed an informed consent form prior to participating in the study and during an informative session presenting the study.
- 11.Chana-Cuevas P, Juri-Claverías C, Alburquerque D, Soto-Olmedo MJ, Benavides-Canales O (2006) Risk factors associated to the presentation of episodes of major depression in a population of outpatients with Parkinson’s disease. Rev Neurol 42(9):521–524Google Scholar
- 16.Santos H, García-Antelo MJ, Ivánovic-Barbeito Y, Díaz-Silva JJ, Sobrido MJ (2012) Tratamiento de los trastornos de la marcha en la enfermedad de Parkinson. Rev Neurol 54(5):61–68Google Scholar
- 24.Martínez de la Iglesia J, Onís Vilches MC, Dueñas Herrero R, Albert Colomer C, Aguado Taberné C, Luque Luque R (2002) Versión española del Cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. MEDIFAM 12:620–630Google Scholar
- 29.Opara JA, Brola W, Leonardi M, Błaszczyk B (2012) Quality of life in Parkinson’s disease. J Med Life 5:375–381Google Scholar